Prelude therapeutics to participate at the 4th annual evercore isi healthconx conference

Wilmington, del., nov. 23, 2021 (globe newswire) -- prelude therapeutics inc. (nasdaq: prld), a clinical-stage precision oncology company, today announced that kris vaddi, phd, chief executive officer, will participate in a fireside chat at the 4th annual evercore isi healthconx conference taking place on wednesday, december 1, 2021 at 9:15 am et.
PRLD Ratings Summary
PRLD Quant Ranking